New depression pill TJ0113 enters Mid-Stage trial
Symptom relief
Recruiting now
This study tests whether an experimental drug called TJ0113 can safely reduce depression symptoms. About 150 adults with moderate to severe depression will take either TJ0113 (at 200 mg or 400 mg) or a placebo daily for 8 weeks. Researchers will measure changes in depression scor…
Phase: PHASE2 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Symptom relief
Last updated May 17, 2026 08:00 UTC